Low Prevalence of Ciprofloxacin-Resistant Neisseria gonorrhoeae in Nuuk, Greenland
During a 35-day period, 32 isolates of Neisseria gonorrhoeae strains were collected by culture from patients with positive nucleic acid amplification test results in Nuuk, Greenland, where ciprofloxacin is the preferred treatment. All isolates were quinolone susceptible, suggesting that resistance i...
Gespeichert in:
Veröffentlicht in: | Sexually transmitted diseases 2013-08, Vol.40 (8), p.639-640 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 640 |
---|---|
container_issue | 8 |
container_start_page | 639 |
container_title | Sexually transmitted diseases |
container_volume | 40 |
creator | Pedersen, Michael Lynge Clausen-Dichow, Pernille Poulsen, Peter Nyborg, Hanne Jensen, Jørgen Skov |
description | During a 35-day period, 32 isolates of Neisseria gonorrhoeae strains were collected by culture from patients with positive nucleic acid amplification test results in Nuuk, Greenland, where ciprofloxacin is the preferred treatment. All isolates were quinolone susceptible, suggesting that resistance is rare. Sampling patients for culture before treatment may prove useful in reestablishing surveillance. |
doi_str_mv | 10.1097/01.OLQ.0000430780.79488.0f |
format | Article |
fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1430187366</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>48511632</jstor_id><sourcerecordid>48511632</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4998-3cf24ca422a27829f7f4c93ff9d6096aec56bfbe05fe38d039cbdd9aeb66de3c3</originalsourceid><addsrcrecordid>eNqNkU9v1DAQxS0EokvhI4AiuHAgYfwvtrmhFRSkVQsVnC2vM2azzcbFTlj49ni7pUic8MUa6_fejOcR8pxCQ8Go10Cbi9XnBsoRHJSGRhmhdQPhHllQyVUtJKP3yQKo0LVUVJ2QRzlv4VADfUhOGNfSGAoLcrmK--pTwh9uwNFjFUO17K9TDEP86Xw_1peY-zy5carOsc8ZU--qb3GMKW0iOqz6sTqf56tX1VlCHAc3do_Jg-CGjE9u71Py9f27L8sP9eri7OPy7ar2whhdcx-Y8E4w5pjSzAQVhDc8BNO1YFqHXrbrsEaQAbnugBu_7jrjcN22HXLPT8nLo28Z9_uMebK7PnscygwY52xpWQ7Virftf6BQNkulgoK--AfdxjmN5SOFooy3FKQq1Jsj5VPMOWGw16nfufTLUrCHkCxQW0Kyf0OyNyFZCEX87LbFvN5hdyf9k0oBxBHYx2HClK-GeY_JbtAN0-bGUgkuawaUgy5VfXjSRfb0KNvmKaY7W6ElpS1n_Ddr16bv</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1412361057</pqid></control><display><type>article</type><title>Low Prevalence of Ciprofloxacin-Resistant Neisseria gonorrhoeae in Nuuk, Greenland</title><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>Jstor Complete Legacy</source><source>MEDLINE</source><creator>Pedersen, Michael Lynge ; Clausen-Dichow, Pernille ; Poulsen, Peter ; Nyborg, Hanne ; Jensen, Jørgen Skov</creator><creatorcontrib>Pedersen, Michael Lynge ; Clausen-Dichow, Pernille ; Poulsen, Peter ; Nyborg, Hanne ; Jensen, Jørgen Skov</creatorcontrib><description>During a 35-day period, 32 isolates of Neisseria gonorrhoeae strains were collected by culture from patients with positive nucleic acid amplification test results in Nuuk, Greenland, where ciprofloxacin is the preferred treatment. All isolates were quinolone susceptible, suggesting that resistance is rare. Sampling patients for culture before treatment may prove useful in reestablishing surveillance.</description><identifier>ISSN: 0148-5717</identifier><identifier>EISSN: 1537-4521</identifier><identifier>DOI: 10.1097/01.OLQ.0000430780.79488.0f</identifier><identifier>PMID: 23859910</identifier><identifier>CODEN: STRDDM</identifier><language>eng</language><publisher>United States: Lippincott Williams & Wilkins, a business of Wolters Kluwer Health</publisher><subject>Adult ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Antibiotics ; Cells, Cultured ; Cervix Uteri - immunology ; Cervix Uteri - pathology ; Ciprofloxacin - pharmacology ; Ciprofloxacin - therapeutic use ; Drug Resistance, Microbial - drug effects ; Female ; Gonorrhea ; Gonorrhea - drug therapy ; Gonorrhea - epidemiology ; Gonorrhea - immunology ; Gonorrhoea ; Greenland ; Greenland - epidemiology ; Humans ; Male ; Medical treatment ; Microbial Sensitivity Tests ; Neisseria gonorrhoeae - drug effects ; Neisseria gonorrhoeae - isolation & purification ; Patients ; Prevalence ; Resistance ; Sampling ; Sentinel Surveillance ; Surveillance ; Urethra - immunology ; Urethra - pathology</subject><ispartof>Sexually transmitted diseases, 2013-08, Vol.40 (8), p.639-640</ispartof><rights>Copyright © 2013 American Sexually Transmitted Diseases Association</rights><rights>Copyright 2013 American Sexually Transmitted Diseases Association</rights><rights>Copyright Lippincott Williams & Wilkins Aug 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4998-3cf24ca422a27829f7f4c93ff9d6096aec56bfbe05fe38d039cbdd9aeb66de3c3</citedby><cites>FETCH-LOGICAL-c4998-3cf24ca422a27829f7f4c93ff9d6096aec56bfbe05fe38d039cbdd9aeb66de3c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/48511632$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/48511632$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,776,780,799,27901,27902,30976,30977,57992,58225</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23859910$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pedersen, Michael Lynge</creatorcontrib><creatorcontrib>Clausen-Dichow, Pernille</creatorcontrib><creatorcontrib>Poulsen, Peter</creatorcontrib><creatorcontrib>Nyborg, Hanne</creatorcontrib><creatorcontrib>Jensen, Jørgen Skov</creatorcontrib><title>Low Prevalence of Ciprofloxacin-Resistant Neisseria gonorrhoeae in Nuuk, Greenland</title><title>Sexually transmitted diseases</title><addtitle>Sex Transm Dis</addtitle><description>During a 35-day period, 32 isolates of Neisseria gonorrhoeae strains were collected by culture from patients with positive nucleic acid amplification test results in Nuuk, Greenland, where ciprofloxacin is the preferred treatment. All isolates were quinolone susceptible, suggesting that resistance is rare. Sampling patients for culture before treatment may prove useful in reestablishing surveillance.</description><subject>Adult</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotics</subject><subject>Cells, Cultured</subject><subject>Cervix Uteri - immunology</subject><subject>Cervix Uteri - pathology</subject><subject>Ciprofloxacin - pharmacology</subject><subject>Ciprofloxacin - therapeutic use</subject><subject>Drug Resistance, Microbial - drug effects</subject><subject>Female</subject><subject>Gonorrhea</subject><subject>Gonorrhea - drug therapy</subject><subject>Gonorrhea - epidemiology</subject><subject>Gonorrhea - immunology</subject><subject>Gonorrhoea</subject><subject>Greenland</subject><subject>Greenland - epidemiology</subject><subject>Humans</subject><subject>Male</subject><subject>Medical treatment</subject><subject>Microbial Sensitivity Tests</subject><subject>Neisseria gonorrhoeae - drug effects</subject><subject>Neisseria gonorrhoeae - isolation & purification</subject><subject>Patients</subject><subject>Prevalence</subject><subject>Resistance</subject><subject>Sampling</subject><subject>Sentinel Surveillance</subject><subject>Surveillance</subject><subject>Urethra - immunology</subject><subject>Urethra - pathology</subject><issn>0148-5717</issn><issn>1537-4521</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><recordid>eNqNkU9v1DAQxS0EokvhI4AiuHAgYfwvtrmhFRSkVQsVnC2vM2azzcbFTlj49ni7pUic8MUa6_fejOcR8pxCQ8Go10Cbi9XnBsoRHJSGRhmhdQPhHllQyVUtJKP3yQKo0LVUVJ2QRzlv4VADfUhOGNfSGAoLcrmK--pTwh9uwNFjFUO17K9TDEP86Xw_1peY-zy5carOsc8ZU--qb3GMKW0iOqz6sTqf56tX1VlCHAc3do_Jg-CGjE9u71Py9f27L8sP9eri7OPy7ar2whhdcx-Y8E4w5pjSzAQVhDc8BNO1YFqHXrbrsEaQAbnugBu_7jrjcN22HXLPT8nLo28Z9_uMebK7PnscygwY52xpWQ7Virftf6BQNkulgoK--AfdxjmN5SOFooy3FKQq1Jsj5VPMOWGw16nfufTLUrCHkCxQW0Kyf0OyNyFZCEX87LbFvN5hdyf9k0oBxBHYx2HClK-GeY_JbtAN0-bGUgkuawaUgy5VfXjSRfb0KNvmKaY7W6ElpS1n_Ddr16bv</recordid><startdate>20130801</startdate><enddate>20130801</enddate><creator>Pedersen, Michael Lynge</creator><creator>Clausen-Dichow, Pernille</creator><creator>Poulsen, Peter</creator><creator>Nyborg, Hanne</creator><creator>Jensen, Jørgen Skov</creator><general>Lippincott Williams & Wilkins, a business of Wolters Kluwer Health</general><general>Copyright American Sexually Transmitted Diseases Association</general><general>Lippincott Williams & Wilkins Ovid Technologies</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>7QL</scope><scope>7T2</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20130801</creationdate><title>Low Prevalence of Ciprofloxacin-Resistant Neisseria gonorrhoeae in Nuuk, Greenland</title><author>Pedersen, Michael Lynge ; Clausen-Dichow, Pernille ; Poulsen, Peter ; Nyborg, Hanne ; Jensen, Jørgen Skov</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4998-3cf24ca422a27829f7f4c93ff9d6096aec56bfbe05fe38d039cbdd9aeb66de3c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotics</topic><topic>Cells, Cultured</topic><topic>Cervix Uteri - immunology</topic><topic>Cervix Uteri - pathology</topic><topic>Ciprofloxacin - pharmacology</topic><topic>Ciprofloxacin - therapeutic use</topic><topic>Drug Resistance, Microbial - drug effects</topic><topic>Female</topic><topic>Gonorrhea</topic><topic>Gonorrhea - drug therapy</topic><topic>Gonorrhea - epidemiology</topic><topic>Gonorrhea - immunology</topic><topic>Gonorrhoea</topic><topic>Greenland</topic><topic>Greenland - epidemiology</topic><topic>Humans</topic><topic>Male</topic><topic>Medical treatment</topic><topic>Microbial Sensitivity Tests</topic><topic>Neisseria gonorrhoeae - drug effects</topic><topic>Neisseria gonorrhoeae - isolation & purification</topic><topic>Patients</topic><topic>Prevalence</topic><topic>Resistance</topic><topic>Sampling</topic><topic>Sentinel Surveillance</topic><topic>Surveillance</topic><topic>Urethra - immunology</topic><topic>Urethra - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pedersen, Michael Lynge</creatorcontrib><creatorcontrib>Clausen-Dichow, Pernille</creatorcontrib><creatorcontrib>Poulsen, Peter</creatorcontrib><creatorcontrib>Nyborg, Hanne</creatorcontrib><creatorcontrib>Jensen, Jørgen Skov</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Sexually transmitted diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pedersen, Michael Lynge</au><au>Clausen-Dichow, Pernille</au><au>Poulsen, Peter</au><au>Nyborg, Hanne</au><au>Jensen, Jørgen Skov</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Low Prevalence of Ciprofloxacin-Resistant Neisseria gonorrhoeae in Nuuk, Greenland</atitle><jtitle>Sexually transmitted diseases</jtitle><addtitle>Sex Transm Dis</addtitle><date>2013-08-01</date><risdate>2013</risdate><volume>40</volume><issue>8</issue><spage>639</spage><epage>640</epage><pages>639-640</pages><issn>0148-5717</issn><eissn>1537-4521</eissn><coden>STRDDM</coden><abstract>During a 35-day period, 32 isolates of Neisseria gonorrhoeae strains were collected by culture from patients with positive nucleic acid amplification test results in Nuuk, Greenland, where ciprofloxacin is the preferred treatment. All isolates were quinolone susceptible, suggesting that resistance is rare. Sampling patients for culture before treatment may prove useful in reestablishing surveillance.</abstract><cop>United States</cop><pub>Lippincott Williams & Wilkins, a business of Wolters Kluwer Health</pub><pmid>23859910</pmid><doi>10.1097/01.OLQ.0000430780.79488.0f</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0148-5717 |
ispartof | Sexually transmitted diseases, 2013-08, Vol.40 (8), p.639-640 |
issn | 0148-5717 1537-4521 |
language | eng |
recordid | cdi_proquest_miscellaneous_1430187366 |
source | Applied Social Sciences Index & Abstracts (ASSIA); Jstor Complete Legacy; MEDLINE |
subjects | Adult Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Antibiotics Cells, Cultured Cervix Uteri - immunology Cervix Uteri - pathology Ciprofloxacin - pharmacology Ciprofloxacin - therapeutic use Drug Resistance, Microbial - drug effects Female Gonorrhea Gonorrhea - drug therapy Gonorrhea - epidemiology Gonorrhea - immunology Gonorrhoea Greenland Greenland - epidemiology Humans Male Medical treatment Microbial Sensitivity Tests Neisseria gonorrhoeae - drug effects Neisseria gonorrhoeae - isolation & purification Patients Prevalence Resistance Sampling Sentinel Surveillance Surveillance Urethra - immunology Urethra - pathology |
title | Low Prevalence of Ciprofloxacin-Resistant Neisseria gonorrhoeae in Nuuk, Greenland |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T18%3A05%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Low%20Prevalence%20of%20Ciprofloxacin-Resistant%20Neisseria%20gonorrhoeae%20in%20Nuuk,%20Greenland&rft.jtitle=Sexually%20transmitted%20diseases&rft.au=Pedersen,%20Michael%20Lynge&rft.date=2013-08-01&rft.volume=40&rft.issue=8&rft.spage=639&rft.epage=640&rft.pages=639-640&rft.issn=0148-5717&rft.eissn=1537-4521&rft.coden=STRDDM&rft_id=info:doi/10.1097/01.OLQ.0000430780.79488.0f&rft_dat=%3Cjstor_proqu%3E48511632%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1412361057&rft_id=info:pmid/23859910&rft_jstor_id=48511632&rfr_iscdi=true |